Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,086external-prioritypatent/US5330762A/en
Application filed by Alza CorpfiledCriticalAlza Corp
Publication of MX9306998ApublicationCriticalpatent/MX9306998A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se provee una forma de dosis para administrar un fármaco de la fórmula:(ver fórmula I) a un paciente para producir un beneficio ansiolítico en elpaciente.A dosage form is provided to administer a drug of the formula: (see formula I) to a patient to produce an anxiolytic benefit in the patient.
MX9306998A1993-01-271993-10-08
A THERAPEUTIC COMPOSITION OF TANDOSPIRONE AND A DOSAGE FORM TO ADMINISTER IT.
MX9306998A
(en)
USE OF 2'2'-DIFLUORONUCLEOSIDS FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL PRODUCT AND COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING THEM
14β-H-STEROLS CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND THE APPLICATION OF THESE DERIVATIVES FOR THE PREPARATION OF MEDICINES OF REGULATING MEIOSE